Knight Therapeutics (GUD) Stock Chart & Stock Price History C$6.01 +0.04 (+0.67%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Knight Therapeutics Stock Price Performance 5 Day Performance-2.75%1 Month Performance+8.88%3 Month Performance+14.48%6 Month Performance+2.74%Year-To-Date Performance+12.55%1 Year Performance+10.68% Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GUD Stock Chart for Wednesday, March, 26, 2025 GUD Chart by TradingViewRemove Ads Knight Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/25/2025C$5.97C$6.01+0.67%C$6.03C$5.9868,859 shsC$607.91 million03/24/2025C$6.18C$5.97-3.40%C$6.20C$5.9276,056 shsC$603.87 million03/21/2025C$6.27C$6.18-1.44%C$6.29C$6.15125,142 shsC$625.11 million03/20/2025C$6.25C$6.27+0.32%C$6.45C$6.19220,118 shsC$634.21 million03/19/2025C$6.19C$6.25+0.97%C$6.25C$6.1655,412 shsC$632.19 million03/18/2025C$6.17C$6.19+0.32%C$6.25C$6.1680,863 shsC$626.12 million03/17/2025C$5.99C$6.17+3.01%C$6.20C$6.07197,811 shsC$624.10 million03/14/2025C$5.88C$5.99+1.87%C$5.99C$5.8557,293 shsC$605.89 million03/13/2025C$6.10C$5.88-3.61%C$6.10C$5.8645,041 shsC$594.76 million03/12/2025C$6.00C$6.10+1.67%C$6.15C$6.03232,912 shsC$617.02 million Get the Latest News and Ratings for GUD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/11/2025C$5.45C$6.00+10.09%C$6.22C$5.69517,394 shsC$606.90 million03/10/2025C$5.48C$5.45-0.55%C$5.61C$5.4264,832 shsC$551.27 million03/07/2025C$5.55C$5.48-1.26%C$5.58C$5.4750,231 shsC$554.30 million03/06/2025C$5.60C$5.55-0.89%C$5.66C$5.5492,215 shsC$561.38 million03/05/2025C$5.55C$5.60+0.90%C$5.62C$5.5534,996 shsC$566.44 million03/04/2025C$5.50C$5.55+0.91%C$5.58C$5.4392,111 shsC$561.38 million03/03/2025C$5.49C$5.50+0.18%C$5.63C$5.4744,834 shsC$556.33 million02/28/2025C$5.51C$5.49-0.36%C$5.53C$5.4773,554 shsC$555.31 million02/27/2025C$5.52C$5.51-0.18%C$5.60C$5.5058,774 shsC$557.34 million02/26/2025C$5.56C$5.52-0.72%C$5.62C$5.5218,248 shsC$558.35 million02/25/2025C$5.63C$5.56-1.24%C$5.63C$5.5424,826 shsC$562.39 million Related Companies CRON Stock Price Chart TLRY Stock Price Chart ACB Stock Price Chart WEED Stock Price Chart CPH Stock Price Chart OGI Stock Price Chart CRDL Stock Price Chart RX Stock Price Chart HLS Stock Price Chart SUGR Stock Price Chart Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:GUD) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
